Depression treatment patterns among individuals with osteoarthritis: a cross sectional study

BMC Psychiatry

Usha Sambamoorthi¹  Xiaoyun Pan¹  Parul Agarwal¹ 

[1] School of Pharmacy, Department of Pharmaceutical Systems and Policy, West Virginia University, Morgantown, WV, USA

关键词: Depression treatment;    MEPS;    Psychotherapy;    Antidepressants;    Arthritis;   

Others  :  1124072
DOI  :  10.1186/1471-244X-13-121

 received in 2012-11-05, accepted in 2013-04-09,  发布年份 2013

【 摘 要 】

Background

Arthritis and depression often co-occur; however, studies that describe patterns of depression treatment among individuals with arthritis are scant. The purpose of the study was to examine depression treatment patterns among individuals with osteoarthritis (OA) by predisposing, enabling, need factors, personal health practices and external health environment.

Methods

Retrospective cross-sectional design was used. Data were obtained from 2008 and 2010 Medical Expenditure Panel Survey (MEPS). The sample consisted of 647adults aged over 21 years with depression and OA. Depression treatment was categorized as: 1) No treatment;2) antidepressant use only and 3) both antidepressants and psychotherapy (combination therapy). Chi- square tests and multinomial logistic regressions were used to describe patterns of depression treatment. All analysis was performed using Statistical Analysis Software (SAS) version 9.3.

Results

Overall, 13.0% of the study sample reported no depression treatment, 67.8% used antidepressants only and 19.2% used combination therapy. Among individuals with OA significant subgroup differences in depression treatment were observed. For example, African Americans were less likely to report depression treatment compared to whites [antidepressants: AOR=0.33, 95% CI=0.21,0.51; combination therapy: AOR=0.39, 95% CI=0.23, 0.65]. Elderly adults were more likely to receive antidepressants and less likely to receive psychotherapy as compared to younger adults [AOR=0.53, 95% CI= 0.28,0.98]. Adults with anxiety were more likely to report depression treatment compared to those without anxiety [antidepressants: AOR=1.53, 95% CI=1.06, 2.22; combination therapy: AOR=3.52, 95% CI=2.40, 5.15].

Conclusion

Future research needs to examine the reason for low rates of combination therapy as well as subgroup differences in combination therapy among individuals with OA.

【 授权许可】

   
2013 Agarwal et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Murphy LB, Sacks JJ, Brady TJ, Hootman JM, Chapman DP: Anxiety and depression among US adults with arthritis: prevalence and correlates. Arthritis Care Res 2012, 64(7):968-976. Epub 2012/05/03
• [2]Tander B, Cengiz K, Alayli G, Ilhanli I, Canbaz S, Canturk F: A comparative evaluation of health related quality of life and depression in patients with fibromyalgia syndrome and rheumatoid arthritis. Rheumatol Int 2008, 28(9):859-865. Epub 2008/03/05
• [3]Lempp H, Ibrahim F, Shaw T, Hofmann D, Graves H, Thornicroft G: Comparative quality of life in patients with depression and rheumatoid arthritis. Int Rev Psychiatry 2011, 23(1):118-124. Epub 2011/02/23
• [4]Lin EH, Katon W, Von Korff M, Tang L, Williams JW Jr, Kroenke K: Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA 2003, 290(18):2428-2429. Epub 2003/11/13
• [5]Dickens C, Creed F: The burden of depression in patients with rheumatoid arthritis. Rheumatology 2001, 40(12):1327.
• [6]Lowe B, Willand L, Eich W, Zipfel S, Ho AD, Herzog W: Psychiatric comorbidity and work disability in patients with inflammatory rheumatic diseases. Psychosom Med 2004, 66(3):395.
• [7]Dunlop DD, Semanik P, Song J, Manheim LM, Shih V, Chang RW: Risk factors for functional decline in older adults with arthritis. Arthritis Rheum 2005, 52(4):1274-1282.
• [8]Bolen J, Schieb L, Hootman JM, Helmick CG, Theis K, Murphy LB: Differences in the prevalence and severity of arthritis among racial/ethnic groups in the United States, National Health Interview Survey, 2002, 2003, and 2006. Prev Chronic Dis 2010, 7(3):A64. Epub 2010/04/17
• [9]Katona C, Peveler R, Dowrick C, Wessely S, Feinmann C, Gask L: Pain symptoms in depression: definition and clinical significance. Clin Med 2005, 5(4):390-395. Epub 2005/09/06
• [10]Kroenke K, Wu J, Bair MJ, Krebs EE, Damush TM, Tu W: Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain 2011, 12(9):964-973.
• [11]Trivedi MH: The link between depression and physical symptoms. Prim Care Companion J Clin Psychiatry 2004, 6(Suppl 1):12-16.
• [12]Chappell AS, Ossanna MJ, Liu-Seifert H, Iyengar S, Skljarevski V, Li LC: Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain 2009, 146(3):253-260. Epub 2009/07/25
• [13]Branco JC, Zachrisson O, Perrot S, Mainguy Y: A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia. J Rheumatol 2010, 37(4):851-859. Epub 2010/02/17
• [14]Kroenke K, Bair MJ, Damush TM, Wu J, Hoke S, Sutherland J: Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA 2009, 301(20):2099-2110. Epub 2009/05/28
• [15]Gelenberg AJ: Practice Guidelines for the Treatment of Patients With Major Depressive Disorder. American Psychiatric Association; 2010. Available from: http://psychiatryonline.org/content.aspx?bookid=28§ionid=1667485 webcite
• [16]Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ: A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England J Med 2000, 342(20):1462-1470. Epub 2000/05/18
• [17]Andersen RM: Revisiting the behavioral model and access to medical care: does it matter? J Heal Soc Behav 1995, 36(1):1-10. Epub 1995/03/01
• [18]AHRQ: MEPS-HC Sample Design and Collection Process. Rockville: AHRQ; [cited 2011 17th February]; Available from: http://www.meps.ahrq.gov/mepsweb/survey_comp/hc_data_collection.jsp webcite
• [19]AHRQ: MEPS HC-121: 2008 Full Year Consolidated Data File. Center for Financing, Access, and Cost Trends540. Gaither RoadRockville, MD: ; 20850: Agency for Healthcare Research and Quality; 2010 [cited 2012 9th August]; Available from: http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h121/h121doc.shtml webcite
• [20]Machlin S, Cohen J, Elixhauser A, Beauregard K, Steiner C: Sensitivity of household reported medical conditions in the medical expenditure panel survey. Med Care 2009, 47(6):618-625. Epub 2009/05/13
• [21]AHRQ: MEPS HC-120: 2008 Medical Conditions. Center for Financing, Access, and Cost Trends540. Gaither RoadRockville, MD: Agency for Healthcare Research and Quality; 2010. cited 2012 9th August]; Available from: http://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h120/h120doc.shtml webcite
• [22]Sommers J: An Examination of State Estimates Using Multiple Years of Data from the Medical Expenditure Panel Survey, Household Component. : Agency for Healthcare Research and Quality Working Paper No. 06004; 2006. Available from: http://meps.ahrq.gov/mepsweb/data_files/publications/workingpapers/wp_06004.pdf webcite
• [23]Harman JS, Edlund MJ, Fortney JC, Kallas H: The influence of comorbid chronic medical conditions on the adequacy of depression care for older Americans. J Am Geriatr Soc 2005, 53(12):2178-2183.
• [24]Verdu B, Decosterd I, Buclin T, Stiefel F, Berney A: Antidepressants for the treatment of chronic pain. Drugs 2008, 68(18):2611-2632. Epub 2008/12/20
• [25]Gaskin DJ, Richard P: The economic costs of pain in the United States. The J Pain 2012, 13(8):715-724. Epub 2012/05/23
• [26]Marcus SC, Olfson M: National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry 2010, 67(12):1265-1273.
• [27]Mojtabai R, Olfson M: National trends in psychotherapy by office-based psychiatrists. Arch Gen Psychiatry 2008, 65(8):962-970. Epub 2008/08/06
• [28]Olfson M, Marcus SC: National trends in outpatient psychotherapy. Am J Psychiatry 2010, 167(12):1456-1463. Epub 2010/08/06
• [29]Nutting PA, Rost K, Dickinson M, Werner JJ, Dickinson P, Smith JL: Barriers to initiating depression treatment in primary care practice. J Gen Int Med 2002, 17(2):103-111. Epub 2002/02/14
• [30]Simon GE, Fleck M, Lucas R, Bushnell DM: Prevalence and predictors of depression treatment in an international primary care study. Am J Psychiatry 2004, 16(9):1626-1634. Epub 2004/09/01
• [31]Cabral P, Meyer HB, Ames D: Effectiveness of yoga therapy as a complementary treatment for major psychiatric disorders: a meta-analysis. Prim Care companion CNS disorders 2011., 13(4) Epub 2011/12/02
• [32]Cooper LA, Gonzales JJ, Gallo JJ, Rost KM, Meredith LS, Rubenstein LV: The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Med Care 2003, 41(4):479-489. Epub 2003/04/01
• [33]Simpson SM, Krishnan LL, Kunik ME, Ruiz P: Racial disparities in diagnosis and treatment of depression: a literature review. Psychiatr Q 2007, 78(1):3-14. Epub 2006/11/15
• [34]Givens JL, Houston TK, Van Voorhees BW, Ford DE, Cooper LA: Ethnicity and preferences for depression treatment. Gen Hosp Psychiatry 2007, 29(3):182-191. Epub 2007/05/09
• [35]Akincigil A, Olfson M, Walkup JT, Siegel MJ, Kalay E, Amin S: Diagnosis and treatment of depression in older community-dwelling adults: 1992–2005. J Am Geriatr Soc 2011, 59(6):1042-1051. Epub 2011/06/09
• [36]Harman JS, Edlund MJ, Fortney JC: Disparities in the adequacy of depression treatment in the United States. Psychiatr Serv 2004, 55(12):1379-1385. Epub 2004/12/02
• [37]Simon GE, Grothaus L, Durham ML, VonKorff M, Pabiniak C: Impact of visit copayments on outpatient mental health utilization by members of a health maintenance organization. Am J Psychiatry 1996, 153(3):331-338.
• [38]Butler AC, Chapman JE, Forman EM, Beck AT: The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev 2006, 26(1):17-31. Epub 2005/10/04
• [39]Simon GE, Ludman EJ, Linde JA, Operskalski BH, Ichikawa L, Rohde P: Association between obesity and depression in middle-aged women. Gen Hosp Psychiatry 2008, 30(1):32-39.
• [40]Faulconbridge LF, Wadden TA, Berkowitz RI, Pulcini ME, Treadwell T: Treatment of comorbid obesity and major depressive disorder: a prospective pilot study for their combined treatment. J Obes 2011, 2011:870385.